Publicaciones en colaboración con investigadores/as de Consejo Superior de Investigaciones Científicas (71)

2024

  1. Functional proteomics based on protein microarray technology for biomedical research

    Advances in Protein Chemistry and Structural Biology (Academic Press Inc.), pp. 49-65

2023

  1. Enhancement of Tumor Cell Immunogenicity and Antitumor Properties Derived from Platinum-Conjugated Iron Nanoparticles

    Cancers, Vol. 15, Núm. 12

  2. Exploring High-Throughput Immunoassays for Biomarker Validation in Rheumatic Diseases in the Context of the Human Proteome Project

    Journal of Proteome Research, Vol. 22, Núm. 4, pp. 1105-1115

  3. Immune stress suppresses innate immune signaling in preleukemic precursor B-cells to provoke leukemia in predisposed mice

    Nature Communications, Vol. 14, Núm. 1

  4. Improving Properties of Podophyllic Aldehyde-Derived Cyclolignans: Design, Synthesis and Evaluation of Novel Lignohydroquinones, Dual-Selective Hybrids against Colorectal Cancer Cells

    Pharmaceutics, Vol. 15, Núm. 3

  5. Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance

    Nature Communications, Vol. 14, Núm. 1

  6. Minimal residual disease assessment in B-cell precursor acute lymphoblastic leukemia by semi-automated identification of normal hematopoietic cells: A EuroFlow study

    Cytometry Part B - Clinical Cytometry

  7. Systematic Evaluation of Antigenic Stimulation in Chronic Lymphocytic Leukemia: Humoral Immunity as Biomarkers for Disease Evolution

    Cancers, Vol. 15, Núm. 3

  8. The International Consensus Classification of myelodysplastic syndromes and related entities

    Virchows Archiv, Vol. 482, Núm. 1, pp. 39-51

  9. Translational research into frailty from bench to bedside: Salivary biomarkers for inflammaging

    Experimental Gerontology, Vol. 171

2022

  1. A quantitative systems approach to define novel effects of tumour p53 mutations on binding oncoprotein mdm2

    International Journal of Molecular Sciences, Vol. 23, Núm. 1

  2. Cellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignancies

    Blood Advances, Vol. 6, Núm. 3, pp. 774-784

  3. Comprehensive and systematic characterization of multi-functionalized cisplatin nano-conjugate: from the chemistry and proteomic biocompatibility to the animal model

    Journal of Nanobiotechnology, Vol. 20, Núm. 1

  4. Flow cytometric minimal residual disease assessment in B-cell precursor acute lymphoblastic leukaemia patients treated with CD19-targeted therapies — a EuroFlow study

    British Journal of Haematology, Vol. 197, Núm. 1, pp. 76-81

  5. Global Classification of Mast Cell Activation Disorders: An ICD-10-CM–Adjusted Proposal of the ECNM-AIM Consortium

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 10, Núm. 8, pp. 1941-1950

  6. Recurrent NOMO1 Gene Deletion Is a Potential Clinical Marker in Early-Onset Colorectal Cancer and Is Involved in the Regulation of Cell Migration

    Cancers, Vol. 14, Núm. 16

  7. SARS-CoV-2 Infection Triggers Auto-Immune Response in ARDS

    Frontiers in Immunology, Vol. 13

  8. Single-Cell Proteomics: The Critical Role of Nanotechnology

    International Journal of Molecular Sciences, Vol. 23, Núm. 12

  9. Systematic evaluation of plasma signaling cascades by functional proteomics approaches: SARS-CoV-2 infection as model

    Proteomics - Clinical Applications, Vol. 16, Núm. 6

  10. Transient Inhibition of the JAK/STAT Pathway Prevents B-ALL Development in Genetically Predisposed Mice

    Cancer research, Vol. 82, Núm. 6, pp. 1098-1109